Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Misinterpretation of United States Pharmacopeia Chapter <797>

Author(s):  McElhiney Linda F

Issue:  Jan/Feb 2012 - Volume 16, Number 1
View All Articles in Issue

Page(s):  6-10

Misinterpretation of United States Pharmacopeia Chapter <797> Page 1
Misinterpretation of United States Pharmacopeia Chapter <797> Page 2
Misinterpretation of United States Pharmacopeia Chapter <797> Page 3
Misinterpretation of United States Pharmacopeia Chapter <797> Page 4
Misinterpretation of United States Pharmacopeia Chapter <797> Page 5

Download in electronic PDF format for $75

Abstract:  By now, all compounding pharmacists should be aware that United States Pharmacopeia Chapter <797> has been revised. However, the revisions are tedious to read and may be misinterpreted. This article discusses some of the misinterpreted revisions of United States Pharmacopeia Chapter <797> and clarifies the revisions on the topics of Terminology, The Compounder, Facilities and Environment, Personnel Cleansing and Garbing, Assigning Beyond-use Dates, and Testing. Compounders need to take a firm stand with these misinterpretations of United States Pharmacopeia Chapter <797> and educate those who are not thoroughly familiar with the document. Compounders need to be diligent in following these standards to prevent harm to the patients.

Related Keywords: Linda F. McElhiney, PharmD, RPh, FIACP, FASHP, United States Pharmacopeia Chapter <797>, USP, compounded sterile preparations, compounding facilities, garb, beyond-use dates, contamination, testing

Related Categories: ENVIRONMENTAL , STERILE PREPARATIONS, UNITED STATES PHARMACOPEIA CONVENTIONS, PROFESSIONAL ISSUES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Allen Loyd V Jr
Mar/Apr 2020
Pg. 92

PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Allen Loyd V Jr
May/Jun 2020
Pg. 180

Misinterpretation of United States Pharmacopeia Chapter <797>
McElhiney Linda F
Jan/Feb 2012
Pg. 6-10

Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496

Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Kelley Brian
Mar/Apr 2021
Pg. 115-124

Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Allen Loyd V Jr
, Okeke Claudia C
Sep/Oct 2007
Pg. 404-410

Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Okeke Claudia C
Jul/Aug 2007
Pg. 302-305

United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013
Newton David W
Jul/Aug 2013
Pg. 283-288

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating
Allen Loyd V Jr
, Okeke Claudia C
Jul/Aug 2008
Pg. 344-353

Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards
Kastango Eric S
May/Jun 2008
Pg. 216-229

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797>
Allen Loyd V Jr
, Okeke Claudia C
Mar/Apr 2008
Pg. 136-144

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use
Allen Loyd V Jr
, Okeke Claudia C
May/Jun 2008
Pg. 252-257

A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards
Newton David W
, Trissel Lawrence A
Jul/Aug 2004
Pg. 251-263

Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Martin Matt
Sep/Oct 2018
Pg. 401-404

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations
Allen Loyd V Jr
, Okeke Claudia C
Sep/Oct 2008
Pg. 440-443

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control
Allen Loyd V Jr
, Okeke Claudia C
May/Jun 2009
Pg. 234-238

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chater <797> Pharmaceutical Compounding--Sterile Preparations, Part 15: Personnel Training, Cleansing, and Garbing
Okeke Claudia C
, Allen Loyd V Jr
Sep/Oct 2009
Pg. 420-426

Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations
Okeke Claudia C
, Allen Loyd V Jr
May/Jun 2010
Pg. 232-238

Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating
Martin Matt
Jul/Aug 2018
Pg. 303-312

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued)
Okeke Claudia C
, Allen Loyd V Jr
Jul/Aug 2009
Pg. 322-329

Return to Top